Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus corynebacterium parvum (a gynecologic oncology group study)-Reference-Cited by-同舟云学术

Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus corynebacterium parvum (a gynecologic oncology group study)

Published:1986-09 Issue:1 Volume:25 Page:26-36
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Gall S.,Bundy B.,Beecham J.,Whitney C.,Homesley H.,Lifshitz S.,Adcock L.L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference11 articles.

1. Cancer statistics 1980—CA — A;Cancer J. Clinicians,1980

2. Chemotherapy of ovarian cancer: Past and present;Young;Semin. Oncol.,1975

3. Follow-up on a randomized trial of melphalan (M) vs. melphalan plus hexamethylmelamine (H) vs. adriamycin plus cyclophosphamide in advanced ovarian adenocarcinoma;Omura;ASCO, C-537,1981

4. A randomized trial of cyclophosphamide (C) plus adriamycin (A) with or without cisplatinum (P) in ovarian carcinoma;Omura;ASCO, C-403,1982

5. Chemoimmunotherapy in the management of primary stage III ovarian cancer: A Gynecologic Oncology Group study;Creasman;Cancer Treat. Rep.,1979

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Past, present and future targets for immunotherapy in ovarian cancer;Immunotherapy;2014-12

2. Evolution of the Gynecologic Oncology Group Protocols in the Treatment of Epithelial Ovarian Cancer;Clinical Obstetrics & Gynecology;2012-03

3. Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experience;Cancer;2010-08-31

4. Progress in Gynecologic Cancer Research: The Gynecologic Oncology Group Experience;Seminars in Oncology;2008-10

5. Ovaries and Fallopian Tubes;Abeloff's Clinical Oncology;2008